Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,398 | 114 | 99.8% |
| Education | $4.53 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $752.12 | 33 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $354.91 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $289.63 | 11 | $0 (2024) |
| Lundbeck LLC | $287.97 | 17 | $0 (2024) |
| Alkermes, Inc. | $263.64 | 16 | $0 (2024) |
| Axsome Therapeutics, Inc. | $156.96 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $154.48 | 9 | $0 (2024) |
| ITI, Inc. | $55.66 | 3 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $49.31 | 3 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $37.94 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,525 | 71 | ABBVIE INC. ($440.03) |
| 2023 | $775.15 | 38 | AbbVie Inc. ($284.95) |
| 2022 | $101.98 | 6 | Neurocrine Biosciences, Inc. ($32.28) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.16 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: CNS | ||||||
| 12/09/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.36 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: CNS | ||||||
| 11/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.84 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: CNS | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Neuropsychiatry | ||||||
| 10/31/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.71 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.86 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Neuropsychiatry | ||||||
| 10/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Neuroscience | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $0.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $36.16 | General |
| Category: Neuropsychiatry | ||||||
| 09/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: CNS | ||||||
| 09/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 44 | 159 | $17,490 | $6,761 |
| 2022 | 1 | 17 | 20 | $1,600 | $500.08 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 33 | 146 | $16,060 | $6,139 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 13 | $1,430 | $621.76 | 43.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 17 | 20 | $1,600 | $500.08 | 31.3% |
About Olukemi Aina
Olukemi Aina is a Psychiatric/Mental Health healthcare provider based in Melrose Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2021. The National Provider Identifier (NPI) number assigned to this provider is 1124787650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Olukemi Aina has received a total of $2,403 in payments from pharmaceutical and medical device companies, with $1,525 received in 2024. These payments were reported across 115 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,398).
As a Medicare-enrolled provider, Aina has provided services to 61 Medicare beneficiaries, totaling 179 services with total Medicare billing of $7,261. Data is available for 2 years (2022–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Melrose Park, IL
- Active Since 12/13/2021
- Last Updated 03/26/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1124787650
Products in Payments
- VRAYLAR (Drug) $752.12
- REXULTI (Drug) $533.47
- INGREZZA (Drug) $354.91
- Auvelity (Drug) $156.96
- LYBALVI (Drug) $154.60
- INVEGA SUSTENNA (Drug) $154.48
- ARISTADA (Drug) $109.04
- CAPLYTA (Drug) $104.97
- ABILIFY MAINTENA (Drug) $44.13
- FANAPT (Drug) $37.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.